bluuebunny/crossref_metadata_2025_split huggingface dataset:
Healthcare professionals' perceptions of pain in infants at risk for neurological impairment
Authors: Breau Lynn M , McGrath Patrick J , Stevens Bonnie , Beyene Joseph , Camfield Carol S , Finley G Allen , Franck Linda , Howlett Alexandra , O'Brien Karel , Ohlsson Arne 
Published: November 2004

Abstract
Background
To determine whether healthcare professionals perceive the pain of infants differently due to their understanding of that infant's level of risk for neurological impairment.

Method
Neonatal Intensive Care Units (NICU's) at two tertiary pediatric centers. Ninety-five healthcare professionals who practice in the NICU (50 nurses, 19 physicians, 17 respiratory therapists, 9 other) participated. They rated the pain (0–10 scale and 0–6 Faces Pain Scale), distress (0–10), effectiveness of cuddling to relieve pain (0–10) and time to calm without intervention (seconds) for nine video clips of neonates receiving a heel stick. Prior to each rating, they were provided with descriptions that suggested the infant had mild, moderate or severe risk for neurological impairment. Ratings were examined as a function of the level of risk described.

Results
Professionals' ratings of pain, distress, and time to calm did not vary significantly with level of risk, but ratings of the effectiveness of cuddling were significantly lower as risk increased [F (2,93) = 4.4, p = .02]. No differences in ratings were found due to participants' age, gender or site of study. Physicians' ratings were significantly lower than nurses' across ratings.

Conclusion
Professionals provided with visual information regarding an infants' pain during a procedure did not display the belief that infants' level of risk for neurological impairment affected their pain experience. Professionals' estimates of the effectiveness of a nonpharmacological intervention did differ due to level of risk.
Locomotor activity in common spiny mice (Acomys cahirinuse): The effect of light and environmental complexity
Authors: Eilam David 
Published: November 2004

Abstract
Background
Rodents typically avoid illuminated and open areas, favoring dark or sheltered environments for activity. While previous studies focused on the effect of these environmental attributes on the level of activity, the present study tested whether the spatio-temporal structure of activity was also modified in illuminated compared with dark and complex compared with open arenas. For this, we tested common spiny mice (Acomys cahirinus) in empty or stone-containing arenas with lights on or lights off.

Results
In an illuminated or open arena, spiny mice moved in less frequent but longer trips with relatively long distances between consecutive stops. In contrast, in either a dark arena or an arena with stones, the animals took shorter and more frequent trips, with more stops per trip and shorter inter-stop distances. In illuminated arenas spiny mice remained mainly along the walls, whereas locomotion in the center was more prevalent in dark empty arenas, and was carried out along convoluted paths. Increasing environmental complexity by adding stones to either illuminated or dark arenas increased locomotion along straight trajectories and away from walls.

Conclusions
Earlier findings of reduced activity in illuminated or open areas have been extended in the present study by demonstrating changes in the spatio-temporal structure of locomotor behavior. In the more complex arenas (with stones) spiny mice traveled along short straight segments whereas in the open their trips were longer and took the shape of a zigzag path which is more effective against fast or nearby predators. Alternatively, the zigzag path may reflect a difficulty in navigation.
Psychometric performance of an assessment scale for strain in nursing care: The M-NCAS
Authors: Kleinman Leah , Frank Lori , Ciesla Gabrielle , Rupnow Marcia , Brodaty Henry 
Published: November 2004

Abstract
Background
Multiple instruments exist to measure dementia behaviors, but the nursing staff perspective on those behaviors and their level of burden has not been well measured. The goal of this study was to examine the psychometric performance of the Modified Nursing Care Assessment Scale (M-NCAS), a 28-item nurse rating of burden associated with care for institutionalized individuals with dementia. Nurses rate items in terms of extent to which the behavior or characteristic is present ("attitude" domain), and extent to which it is a burden ("strain" domain).

Methods
Data from 282 patients enrolled in a 12-week, double-blind, randomized clinical trial comparing risperidone treatment to placebo was used to evaluate M-NCAS item performance, internal consistency reliability, and construct validity. Empirical subscales were identified via exploratory factor analysis (EFA).

Results
Four poorly-performing items were deleted from further analyses. EFA identified 3 "attitude" subscales and 5 "strain" subscales. Cronbach's alphas were 0.65 and above. Correlation with the Cohen-Mansfield Agitation Inventory and the BEHAVE-AD, clinical ratings of dementia behaviors, were low to moderate.

Conclusion
The M-NCAS provides a valid and reliable means of obtaining care burden ratings from formal caregivers in long-term care, and provides a method for evaluating dementia interventions from the perspective of nursing staff.
Anti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovary
Authors: Fadare Oluwole , Hart Hassan J 
Published: November 2004

Abstract
Background
The IgG autoantibody ANNA-2 (anti-Ri) is a type 2 antineuronal antibody that has been found to bind to highly conserved and widely distributed adult brain proteins encoded by the Nova-1 and Nova-2 genes. Anti-Ri antibodies are typically detected in the serum and cerebrospinal fluids of patients with neurological disorders such as opsoclonus/myoclonus and cerebellar ataxia and in association with gynecologic and breast malignancies.

Case Presentation
This report describes an unusual example of a 33-year-old female patient who developed short-term memory deficits over a 3-month period. An extensive neurological work-up, including a panel of paraneoplastic markers was negative with the exception of a high titer serum Anti-Ri (1:15,3600). A large left ovarian mass was palpated, surgically resected and eventually diagnosed as a mature cystic teratoma. Post-operatively, memory deficits had disappeared within 1 month and serum Anti-Ri titers had decreased significantly to 1:256. An extensive diagnostic work-up for other malignancies was negative.

Conclusion
Although, Anti-Ri antibodies are typically associated with malignancies, this case illustrates the potential association between benign tumors and this autoantibody.
Association between monocyte Fcγ subclass expression and acute coronary syndrome
Authors: Calverley David C , Varteresian Taya , Brass Elizabeth , Tsao-Wei Denice D , Groshen Susan , Mack Wendy J , Buchanan Thomas A , Hodis Howard N , Schreiber Alan D 
Published: November 2004

Abstract
Background
Atherosclerosis lesions contain abundant immunoglobulins complexed with oxidized LDL (OxLDL) that are endocytosed by macrophages to form foam cells. While recent evidence supports a role for the macrophage scavenger receptor pathway in 75–90% of OxLDL uptake, in vitro evidence suggests another potential uptake pathway could involve autoantibody binding to IgG subclass-specific Fc receptors.

Objective and Methods
To address this mechanism from an in vivo standpoint, the objective of this study was to utilize flow cytometry to prospectively determine monocyte Fcγ (FcR) I, II, and III receptor expression levels in patients with acute coronary syndrome (ACS, n = 48), diabetes mellitus (DM, n = 59), or neither (C, n = 88).

Results
Increased FcR I expression was found in the ACS versus DM groups [geometric mean, (95% CI) = 2.26 (2.07, 2.47) versus 1.83 (1.69, 1.98) (p < 0.001)] and versus C [1.90 (1.78, 2.03) (p = 0.005)]. Similar relationships were found with both the FcR II receptor [ACS mean = 4.57 (4.02, 5.19) versus DM 3.61 (3.22, 4.05) (p = 0.021) and versus C 3.86 (3.51, 4.24) (p = 0.09)] and FcR III receptor [ACS mean = 1.55 (1.44, 1.68) versus DM 1.36 (1.27, 1.46) (p = 0.038) and versus C 1.37 (1.30, 1.45) (p = 0.032)]. There was no difference between DM and C groups in FcR I, II or III expression.

Conclusions
This in vivo data supports a possible second OxLDL-autoantibody macrophage uptake mechanism through an Fc receptor-mediated pathway and a potential relationship between atherosclerotic plaque macrophage FcR levels and ACS.
+874(T→A) single nucleotide gene polymorphism does not represent a risk factor for Alzheimer's disease
Authors: Galimberti Lorenza , Arosio Beatrice , Calabresi Carmen , Scurati Silvia , Hamilton Susanna , Carpini Simona Delli , Vergani Carlo , Annoni Giorgio 
Published: November 2004

AbstractIn the recent years, several cytokines have been associated with Alzheimer's disease (AD) development and progression and many studies have correlated this risk with polymorphisms in the genes encoding these molecules. Also the type 1 cytokine interferon (IFN)-γ belongs to a cytokine class that affects the immune function; in fact it plays a major role in defence against viruses and intracellular pathogens but also in the induction of the immune-mediated inflammatory response. The aim of this study was to evaluate the role of IFN-γ in AD by studying the association of +874T→A IFN-γ gene polymorphism with AD. We included in this study 115 AD patients (70 women, 45 men, mean age 80) and 90 sex and age-matched healthy controls (HC, 51 women, 39 men, mean age 82) from northern Italy. Genomic DNA was extracted with the salting-out method from whole blood of all subjects; the genotyping at IFN-γ loci was assessed with ARMS-PCR. The data obtained from the +874T→A IFN-γ gene polymorphism analysis of AD patients and HC lack of any statistically significant differences also when stratified according to gender. In conclusion these results confirm the previous shown lack of association between +874T→A IFN-γ gene polymorphism and the risk of AD. However, other polymorphisms have been demonstrated to influence IFN-γ transcription and since natural killer cells of AD patients show higher production of the cytokine, further analysis will be necessary to clarify the role of this gene in the pathogenesis of the disease.
Impact of Concurrent Versus Sequential Tamoxifen With Radiation Therapy in Early-Stage Breast Cancer Patients Undergoing Breast Conservation Treatment
Authors: Harris Eleanor E.R. , Christensen Vasthi J. , Hwang Wei-Ting , Fox Kevin , Solin Lawrence J. 
Published: November 2004

Purpose To assess the impact of sequencing of tamoxifen and radiation therapy (RT) on outcomes in early-stage breast cancer. Patients and Methods This retrospective study evaluates the effect of the sequence of tamoxifen with RT on outcomes in stage I to II breast cancer patients who underwent breast-conservation treatment (BCT) and received adjuvant tamoxifen, with or without adjuvant chemotherapy. Patients were grouped as concurrent (tamoxifen given during RT followed by continued tamoxifen; 174 patients) and sequential (RT followed by tamoxifen; 104 patients). Results Median follow-up after RT was 8.6 years for both groups. The pathologic T and N stage, race, estrogen and progesterone status, number of positive nodes, and RT were comparable between the two groups (all P ≥ .08). More women age 49 years or younger and women who received chemotherapy were in the sequential group than the concurrent group (6% and 25%, respectively; P < .0001). The sequence of tamoxifen therapy did not influence 10-year local recurrence rates (sequential, 7%; concurrent, 3%; P = .52), overall survival (sequential, 86%; concurrent, 81%; P = .64), or relapse-free survival (sequential, 76%; concurrent, 85%; P = .35). When adjusting age and chemotherapy use in the multivariable Cox model, hazard ratios comparing sequential versus concurrent tamoxifen therapy were 1.56 (95% CI, 0.87 to 2.79), 1.23 (95% CI, 0.63 to 2.41), and 1.22 (95% CI, 0.33 to 4.49) for the overall survival, relapse-free survival, and local recurrence, respectively. Conclusion The therapeutic regimens of tamoxifen given concurrently or sequentially with RT both appear to be reasonable options for patients treated with BCT.
American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004
Authors: Winer Eric P. , Hudis Clifford , Burstein Harold J. , Wolff Antonio C. , Pritchard Kathleen I. , Ingle James N. , Chlebowski Rowan T. , Gelber Richard , Edge Stephan B. , Gralow Julie , Cobleigh Melody A. , Mamounas Eleftherios P. , Goldstein Lori J. , Whelan Timothy J. , Powles Trevor J. , Bryant John , Perkins Cheryl , Perotti Judy , Braun Susan , Langer Amy S. , Browman George P. , Somerfield Mark R. 
Published: November 2004

Purpose To update the 2003 American Society of Clinical Oncology technology assessment on adjuvant use of aromatase inhibitors. Recommendations Based on results from multiple large randomized trials, adjuvant therapy for postmenopausal women with hormone receptor–positive breast cancer should include an aromatase inhibitor in order to lower the risk of tumor recurrence. Neither the optimal timing nor duration of aromatase inhibitor therapy is established. Aromatase inhibitors are appropriate as initial treatment for women with contraindications to tamoxifen. For all other postmenopausal women, treatment options include 5 years of aromatase inhibitors treatment or sequential therapy consisting of tamoxifen (for either 2 to 3 years or 5 years) followed by aromatase inhibitors for 2 to 3, or 5 years. Patients intolerant of aromatase inhibitors should receive tamoxifen. There are no data on the use of tamoxifen after an aromatase inhibitor in the adjuvant setting. Women with hormone receptor–negative tumors should not receive adjuvant endocrine therapy. The role of other biomarkers such as progesterone receptor and HER2 status in selecting optimal endocrine therapy remains controversial. Aromatase inhibitors are contraindicated in premenopausal women; there are limited data concerning their role in women with treatment-related amenorrhea. The side effect profiles of tamoxifen and aromatase inhibitors differ. The late consequences of aromatase inhibitor therapy, including osteoporosis, are not well characterized. Conclusion The Panel believes that optimal adjuvant hormonal therapy for a postmenopausal woman with receptor-positive breast cancer includes an aromatase inhibitor as initial therapy or after treatment with tamoxifen. Women with breast cancer and their physicians must weigh the risks and benefits of all therapeutic options.
High temperature structures of LiKSO4 crystals: normal and incommensurate phases
Authors: Speziali Nivaldo L. , Pimenta Marcos A. 
Published: November 2004

Abstract
Three crystallographic phases have been observed for LiKSO4 crystals between room temperature and the melting point. The study of these phases has involved many researchers for more than two decades of intense experimental investigations. Many publications with controversial results are found in the literature especially concerning the aperiodic character of the intermediate phase (708 K < T < 943 K). A recent careful X-ray diffraction study of the intermediate phase reports evidences of satellite reflections characteristic of an incommensurate modulation. A compilation of the most significant results and the ultimate conclusions are presented here.
Selection on Glycine β-1,3-Endoglucanase Genes Differentially Inhibited by a Phytophthora Glucanase Inhibitor ProteinSequence data from this article have been deposited with EMBL/GenBank Data Libraries under accession nos. AY461847, AY466133, AY466134, AY466135, AY466136, AY466137, AY466138, AY466139, AY466140, AY466141, AY466142, AY466143, AY466144, AY466145, AY466146, AY466147, AY466148, AY466149, AY466150, AY466151, AY466152, AY466153, AY466154, AY466155, AY466156, AY468381, AY468382, AY468383, AY468384, AY468385, AY468386, AY468387, AY468388, AY468389, AY468390, AY468391, AY468392, AY468393, AY468394, AY468395, AY468396, AY468397, AY468398, AY468399, AY468400, AY468401, AY468402, AY468403, AY468404, AY468405, AY468406, AY468407, and AY628413, AY628414, AY628415.
Authors: Bishop J G , Ripoll D R , Bashir S , Damasceno C M B , Seeds J D , Rose J K C 
Published: November 2004

Abstract
Plant endo-β-1,3-glucanases (EGases) degrade the cell wall polysaccharides of attacking pathogens and release elicitors of additional plant defenses. Isozymes EGaseA and EGaseB of soybean differ in susceptibility to a glucanase inhibitor protein (GIP1) produced by Phytophthora sojae, a major soybean pathogen. EGaseA, the major elicitor-releasing isozyme, is a high-affinity ligand for GIP1, which completely inhibits it, whereas EGaseB is unaffected by GIP1. We tested for departures from neutral evolution on the basis of partial sequences of EGaseA and EGaseB from 20 widespread accessions of Glycine soja (the wild progenitor of soybean), from 4 other Glycine species, and across dicotyledonous plants. G. soja exhibited little intraspecific variation at either locus. Phylogeny-based codon evolution models detected strong evidence of positive selection on Glycine EGaseA and weaker evidence for selection on dicot EGases and Glycine EGaseB. Positively selected peptide sites were identified and located on a structural model of EGase bound to GIP1. Positively selected sites and highly variable sites were found disproportionately within 4.5 Å of bound GIP1. Low variation within G. soja EGases, coupled with positive selection in both Glycine and dicot lineages and the proximity of rapidly evolving sites to GIP1, suggests an arms race involving repeated adaptation to pathogen attack and inhibition.
Estimation of Long-Term Effective Population Sizes Through the History of Durum Wheat Using Microsatellite Data
Authors: Thuillet A-C , Bataillon T , Poirier S , Santoni S , David J L 
Published: November 2004

Abstract
Estimation of long-term effective population size (Ne) from polymorphism data alone requires an independent knowledge of mutation rate. Microsatellites provide the opportunity to estimate Ne because their high mutation rate can be estimated from observed mutations. We used this property to estimate Ne in allotetraploid wheat Triticum turgidum at four stages of its history since its domestication. We estimated the mutation rate of 30 microsatellite loci. Allele-specific mutation rates μ were predicted from the number of repeats of the alleles. Effective population sizes were calculated from the diversity parameter θ = 4Neμ. We demonstrated from simulations that the unbiased estimator of θ based on Nei's heterozygosity is the most appropriate for estimating Ne because of a small variance and a relative robustness to variations in the mutation model compared to other estimators. We found a Ne of 32,500 individuals with a 95% confidence interval of [20,739; 45,991] in the wild ancestor of wheat, 12,000 ([5790; 19,300]) in the domesticated form, 6000 ([2831; 9556]) in landraces, and 1300 ([689; 2031]) in recent improved varieties. This decrease illustrates the successive bottlenecks in durum wheat. No selective effect was detected on our loci, despite a complete loss of polymorphism for two of them.
Conserved Locus-Specific Silencing Functions of Schizosaccharomyces pombe sir2+
Authors: Freeman-Cook Lisa L , Gómez Eliana B , Spedale Erik J , Marlett John , Forsburg Susan L , Pillus Lorraine , Laurenson Patricia 
Published: November 2004

AbstractIn Schizosaccharomyces pombe, three genes, sir2+, hst2+, and hst4+, encode members of the Sir2 family of conserved NAD+-dependent protein deacetylases. The S. pombe sir2+ gene encodes a nuclear protein that is not essential for viability or for resistance to treatment with UV or a microtubule-destabilizing agent. However, sir2+ is essential for full transcriptional silencing of centromeres, telomeres, and the cryptic mating-type loci. Chromatin immunoprecipitation results suggest that the Sir2 protein acts directly at these chromosomal regions. Enrichment of Sir2p at silenced regions does not require the HP1 homolog Swi6p; instead, Swi6-GFP localization to telomeres depends in part on Sir2p. The phenotype of sir2 swi6 double mutants supports a model whereby Sir2p functions prior to Swi6p at telomeres and the silent mating-type loci. However, Sir2p does not appear to be essential for the localization of Swi6p to centromeric foci. Cross-complementation experiments showed that the Saccharomyces cerevisiae SIR2 gene can function in place of S. pombe sir2+, suggesting overlapping deacetylation substrates in both species. These results also suggest that, despite differences in most of the other molecules required, the two distantly related yeast species share a mechanism for targeting Sir2p homologs to silent chromatin.
Gene Genealogy and Properties of Test Statistics of Neutrality Under Population Growth
Authors: Sano Akinori , Tachida Hidenori 
Published: November 2004

Abstract
We consider the Wright-Fisher model with exponential population growth and investigate effects of population growth on the shape of genealogy and the distributions of several test statistics of neutrality. In the limiting case as the population grows rapidly, the rapid-growth-limit genealogy is characterized. We obtained approximate expressions for expectations and variances of test statistics in the rapid-growth-limit genealogy and star genealogy. The distributions in the star genealogy are narrower than those in the cases of the simulated and rapid-growth-limit genealogies. The expectations and variances of the test statistics are monotone decreasing functions of the time length of the expansion, and the higher power of R2 against population growth is suggested to be due to their smaller variances rather than to change of the expectations. We also investigated by simulation how quickly the distributions of test statistics approach those of the rapid-growth-limit genealogy.
Genetic Factors That Regulate the Attenuation of the General Stress Response of Yeast
Authors: Bose Sohini , Dutko James A , Zitomer Richard S 
Published: November 2004

Abstract
The general stress response of yeast involves the induction of ∼200 genes in response to any one of several stresses. These genes are activated by Msn2 and repressed by the Srb10 kinase, a member of the mediator complex. Normally, Msn2 is exported from the nucleus, and Srb10 represses STRE gene expression. Under stress, Msn2 relocalizes to the nucleus and, with the relief of Srb10 repression, activates transcription. The stress response is rapid, but quickly attenuated. We show here that this attenuation is due to a nuclear-dependent degradation of Msn2. Msn2 rapidly disappeared from cells after heat or osmotic shock. This disappearance was not due to a change in MSN2 RNA levels, which remain constant during stress. Pulse-chase experiments confirmed the stress-dependent Msn2 degradation. The levels of Msn2 were significantly reduced in msn5 deletion cells that have been shown to constitutively retain Msn2 in the nucleus. The degradation was Srb10-dependent; Msn2 was not degraded in an srb10 deletion mutant. An Msn2 internal deletion mutant was insensitive to Srb10 repression, but was degraded by the Srb10-dependent mechanism. Thus, this mutation uncoupled Srb10 repression from degradation.